The Korean Journal of Internal Medicine This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research

Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Korean J Intern Med. 2024 Mar;39(2):201-202. doi: 10.3904/kjim.2024.048. Epub 2024 Feb 28.NO ABSTRACTPMID:38444062 | PMC:PMC10918369 | DOI:10.3904/kjim.2024.048 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Hae Won Yoo Su Jin Hong Source Type: research

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28.NO ABSTRACTPMID:38444063 | PMC:PMC10918370 | DOI:10.3904/kjim.2024.031 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Won-Il Choi Source Type: research

Cancer treatment-induced bone loss
Korean J Intern Med. 2024 Mar 5. doi: 10.3904/kjim.2023.386. Online ahead of print.ABSTRACTCancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influen...
Source: The Korean Journal of Internal Medicine - March 5, 2024 Category: Internal Medicine Authors: Yong Jun Choi Source Type: research